Alexion Pharmaceuticals Investor
Alexion Pharmaceuticals is a biopharmaceutical company that engages in the development and commercialization of mid-to-late-stage therapies.
Total Funding:
5800000
Headquarters:
Cheshire, Connecticut, United States
Funding Status:
M&A
Employee Number:
1001-5000
Estimated Revenue:
$1B to $10B
Investment Stage:
N/A
Last Funding Type:
Post-IPO Equity
Number Of Exists:
1
Technology:
Anti-infective Drugs
Investor Type:
N/A
Last Funding Date:
1999-02-12
Founded Date:
1992-01-01
Industry:
PharmTech